Excited to see that 130+ teams have already entered CUREBench @NeurIPSConf 2025 Challenge Start here: curebench.ai Evaluate AI deeply and broadly for therapeutics @GaoShanghua @cziscience @MilkenInstitute @BiswasFamilyFdn @cziscience Rare as One program @harvardmed @BrighamWomens @HarvardDBMI @harvardmed @KempnerInst @MIT @broadinstitute

🌍 Excited to open up our global evaluation of AI for drug decision-making and therapeutic reasoning @GaoShanghua Want to shape the future of therapeutic AI, from understanding existing medicines to developing new treatments for diseases with limited options? Start here: txagentevals.curebench.ai How you can participate: 1️⃣ Evaluate TxAgent Test-drive TxAgent, our AI built for therapeutic reasoning across all drugs since 1939, powered by a universal toolbox of 200+ tools. Assess its reasoning on accuracy, clinical relevance, drug safety, and more, each evaluation takes ~10 minutes. Learn about TxAgent: zitniklab.hms.harvard.edu/Tx… and github.com/mims-harvard/TxAg… 2️⃣ Challenge the AI Submit your toughest therapeutic questions: rare diseases, unmet patient needs, or how to safely extend existing treatments, including combination therapies and personalized treatments. Help build an open library of challenges and shape smarter biomedical AI @GaoShanghua @ZKong50693 @RichardYXZhu @xiaorui_su @CurtGinder Sufian Aldogom Thanks to our many partners: @HarvardDBMI @harvardmed @Harvard @KempnerInst @harvard_data @MIT @broadinstitute @BrighamWomens @MilkenInstitute @BiswasFamilyFdn @cziscience